The global biomaterials market is witnessing remarkable growth due to the increasing demand for advanced medical implants, regenerative medicine solutions, and minimally invasive surgical procedures. The global biomaterials market size was estimated at USD 236.99 billion in 2025 and is projected to reach USD 836.54 billion by 2033, growing at a CAGR of 17.25% from 2026 to 2033. Rising cases of musculoskeletal disorders, chronic skeletal conditions, and age-related orthopedic complications are significantly boosting the adoption of biomaterial-based implants across healthcare systems worldwide. Biomaterials are becoming essential in improving patient outcomes, accelerating recovery time, and enhancing the durability of implants used in orthopedic, dental, cardiovascular, and tissue engineering applications. Increasing healthcare investments and technological advancements in implantable devices are further driving market expansion across developed and emerging economies.

The growing focus on regenerative medicine and personalized healthcare is also contributing to the rapid adoption of biomaterials in modern medical treatments. Biomaterials play a critical role in supporting tissue regeneration, wound healing, and the development of bioengineered implants. Healthcare providers are increasingly integrating innovative biomaterial technologies to improve surgical precision and long-term treatment effectiveness. The demand for advanced implants and bioresorbable materials is growing rapidly as healthcare systems seek more efficient and patient-friendly solutions. Furthermore, ongoing research in nanotechnology, multifunctional composites, and bioactive materials is opening new opportunities for manufacturers and research organizations operating in the biomaterials industry.

Download a free sample copy of the Biomaterials market report to understand detailed coverage and inclusions in the final report

Key Market Trends & Insights

The North America biomaterials market held the largest share of 38.11% of the global market in 2025. The region continues to dominate due to advanced healthcare infrastructure, increasing adoption of regenerative medicine, and the presence of leading biomaterials manufacturers. Strong investments in medical research, favorable reimbursement policies, and rising demand for minimally invasive procedures are supporting market growth across North America. The biomaterials industry in the U.S. is expected to grow significantly over the forecast period, driven by rising healthcare spending and continuous innovation in implant technologies.
By product, the metallic segment held the largest market share of 40.56% in 2025. Metallic biomaterials are widely used in orthopedic implants, dental implants, cardiovascular devices, and trauma fixation applications due to their superior strength, durability, and biocompatibility. Increasing demand for titanium, stainless steel, cobalt-chromium alloys, and advanced metallic composites is supporting segment growth. Manufacturers are focusing on developing corrosion-resistant and lightweight metallic biomaterials to improve implant performance and patient comfort.
Based on application, the orthopedic segment held the largest market share in 2025. The growing incidence of osteoporosis, arthritis, bone fractures, and musculoskeletal disorders is increasing the demand for orthopedic implants and joint replacement procedures. Biomaterials are extensively utilized in knee replacements, hip implants, spinal implants, and bone graft substitutes to enhance implant stability and accelerate healing. The rising aging population and growing sports-related injuries are further contributing to the expansion of the orthopedic biomaterials segment.

Looking for more specific insights? Customize this report to suite your business needs

Key Companies & Market Share Insights

The global market is dominated by a mix of established multinational corporations and emerging specialized players. Major companies, including Thermo Fisher Scientific, Danaher, Merck KGaA, Sartorius Stedim Biotech, Lonza, WuXi AppTec, and Berkeley Lights, maintain a strong market presence through extensive product portfolios, robust R&D capabilities, and strategic partnerships. These players focus on innovation, acquisitions, and regional expansion to strengthen their competitive positioning in high-growth markets.
Regionally, Europe follows North America in market share, supported by technological advancements, increasing demand for advanced implants, and supportive regulatory frameworks. Countries across Europe are actively investing in biomaterial research and next-generation medical devices to improve patient outcomes and healthcare efficiency. The Asia Pacific region is projected to witness the fastest growth, fueled by expanding healthcare infrastructure, rising medical tourism, and the growing presence of global biomaterials companies targeting emerging economies such as China, India, and Japan.
Mid-sized and emerging companies are increasingly contributing to market growth through focused product development in niche segments, including bioresorbable polymers, multifunctional composites, and nanocoated implants. Companies such as Advanced Instruments, CircleDNA, Viome, and Bioniq are gaining traction by offering innovative solutions in regenerative medicine and personalized implants. Their flexibility in research and development and their ability to address specific clinical requirements allow them to compete effectively with larger market participants in specialized medical applications.
Strategic mergers, acquisitions, and collaborations continue to reshape the competitive landscape of the biomaterials industry. Companies are investing heavily in expanding production capabilities, accessing advanced technologies, and strengthening their presence in untapped regional markets. The combination of innovation-driven startups and resource-rich established companies is creating a highly dynamic business environment that supports long-term growth and accelerates the adoption of next-generation biomaterials across a wide range of healthcare applications.

Key Biomaterials Companies:

Medtronic
Evonik Industries AG
Carpenter Technology Corporation
Berkeley Advanced Biomaterials
Invibio Ltd.
Zimmer Biomet Holdings, Inc.
BASF SE
Covalon Technologies Ltd.
Stryker
Johnson & Johnson
Dentsply Sirona
CoorsTek Inc.
Corbion
Regenity Biosciences

Explore Grand View Horizon to see global and regional level statistics related to the Biomaterials Market

Grand View Research offers

Focused market intelligence reports on specific geographies or high-growth segments.
Extended forecast timelines for long-term planning.
Competitor Benchmarking and Supply Chain Analysis
Inclusion of regulatory and policy assessments.
Inclusion of custom data models, KPIs, or applications unique to your business
Specific high-impact Data Decks and Tables to support effective decision making
And much more…

Looking for a report customized to your requirements? Explore our Custom Research Offering

Biomaterials Industry Advances with Nanocoated Implant Innovations

The global biomaterials market size was estimated at USD 236.99 billion in 2025 and is projected to reach USD 836.54 billion by 2033, growing at a CAGR of 17.25